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Abstract
Autophagy is a fundamental cellular process that eliminates long-lived proteins and damaged
organelles through lysosomal degradation pathway. Cigarette smoke (CS)-mediated oxidative
stress induces cytotoxic responses in lung cells. However, the role of autophagy and its
mechanism in CS-mediated cytotoxic responses is not known. We hypothesized that NAD+-
dependent deacetylase, sirtuin 1 (SIRT1) plays an important role in regulating autophagy in
response to CS. CS exposure resulted in induction of autophagy in lung epithelial cells, fibroblasts
and macrophages. Pretreatment of cells with SIRT1 activator resveratrol attenuated CS-induced
autophagy whereas the SIRT1 inhibitor, sirtinol, augmented CS-induced autophagy. Elevated
levels of autophagy were induced by CS in the lungs of SIRT1 deficient mice. Inhibition of
poly(ADP-ribose)-polymerase-1 (PARP-1) attenuated CS-induced autophagy via SIRT1
activation. These data suggest that the SIRT1-PARP-1 axis plays a critical role in the regulation of
CS-induced autophagy and have important implications in understanding the mechanisms of CS-
induced cell death and senescence.
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INTRODUCTION
Cigarette smoke (CS) contains numerous oxidants/free radicals as well as chemical
compounds that induce oxidative stress and are involved in the pathogenesis of lung and
heart diseases. CS accelerates cell death and senescence both through direct mechanisms
mediated by oxidants/free radicals as well as via generation of oxidants from inflammatory
cells in chronic inflammatory lung diseases including chronic obstructive pulmonary disease
(COPD) [1–2]. Although there is emerging evidence that CS-mediated cell death and
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senescence increase the susceptibility to diseases, the exact mechanism by which cigarette
smoking accelerates cell death and senescence remains unclear.
Autophagy is a fundamental cellular process that eliminates long-lived proteins and
damaged organelles through a lysosomal degradation pathway, and has been suggested to
have an essential function in maintaining cellular homeostasis [3]. The autophagic process is
initiated by sequestering redundant cytoplasmic contents within double-membrane structures
termed autophagosomes. The autophagosome fuses with a lysosome, and its contents are
degraded and recycled [4]. Although autophagy occurs at basal levels in all cells to maintain
cellular homeostasis, recent reports show that autophagy is also induced in response to
environmental stresses, such as pathogen infections, starvation and oxidative stress [4–7].
Although, autophagy plays a protective role in overcoming the exogenous stress, prolonged
and excessive autophagy can lead to cell death [8–9]. Failure to regulate autophagy has been
implicated in pathogenesis of cancer, cardiovascular failure, immune disease, skeletal
muscle atrophy and neurodegenerative disorders [10–17]. Recent studies have showed that
increased autophagy occurs in lungs of patients with COPD and in lung cells of mouse
exposed to CS [18–19]. However, the underlying mechanism for CS-induced autophagy was
not studied.
Sirtuin 1 (SIRT1), the mammalian ortholog of yeast silent information regulator 2 (Sir2), is
an NAD+-dependent deacetylase which is shown to be an anti-inflammatory and anti-aging
protein [20]. SIRT1 is involved in diverse physiological functions, including gene silencing,
stress resistance, apoptosis, inflammation, senescence and aging [2,21–26]. These
physiological functions of SIRT1 are mediated by deacetylation of histones and several
important transcription factors such as forkhead box O3 (FoxO3), p53 and nuclear factor-κB
(NF-κB) [20,22–23,27–29]. SIRT1 activity is also regulated by NAD+ depletion induced by
oxidative stress or activation of the NAD+-dependent enzyme poly(ADP-ribose)-
polymerase-1 (PARP-1) [30–31]. It has recently been shown that SIRT1 regulates
autophagy under calorie restriction/starvation [32]. Moreover, we have recently shown that
SIRT1 levels/activity is decreased in response to CS exposure in vitro in macrophages and
epithelial cells as well as in lungs of smokers and patients with COPD [20,25,30]. However,
the role of SIRT1 and PARP-1 on CS-mediated autophagy is not known. Therefore, we
hypothesized that SIRT1 plays an important role in regulating CS-mediated autophagy in
lung cells. We studied the effect of CS on induction of autophagy in different lung cell types
in vitro and in mouse lung in vivo, and determined that the SIRT1-PARP1 axis regulates
autophagy.
MATERIALS AND METHODS
Reagents
Penicillin-Streptomycin, L-glutamine and RPMI-1640 were obtained from Gibco BRL
(Grand Island, NY). Fetal bovine serum (FBS) was obtained from HyClone Laboratories
(Logan, UT). Dulbecco’s modified Eagle’s medium-Ham’s F12 50:50 mixture (DMEM/
F-12) was purchased from Mediatech (Manassas, VA). Amphotericin B was purchased from
Lonza (Walkersville, MD). Resveratrol was purchased from Biomol (Plymouth Meeting,
PA). Sirtinol was procured from Sigma (St. Louis, MO). 3-aminobenzamide (3-AB) was
purchased from Calbiochem (La Jolla, CA).
Cell culture and treatments
Human bronchial epithelial cells (H292) and human fetal lung fibroblasts (HFL1) were
obtained from American Type Culture Collection (Manassas, VA). H292 cells were cultured
in RPMI-1640 supplemented with 10% FBS, 2 mM L-glutamine, 100 μg/ml penicillin and
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100 U/ml streptomycin. HFL1 cells were cultured in DMEM-F12 supplemented with 10%
FBS, 100 μg/ml penicillin, 100 U/ml streptomycin, and 1 μg/ml amphotericin B. Human
bronchial epithelial cells (Beas-2B) were grown in DMEM-F12 supplemented with 5% FBS,
15 mM HEPES, 100 μg/ml penicillin, and 100 U/ml streptomycin. Human monocyte-
marcophage cell line (MonoMac6), which was established from peripheral blood of patient
with monoblastic leukemia, were grown in RPMI-1640 supplemented with 10% FBS, 2 mM
L-glutamine, 100 μg/ml penicillin and 100 U/ml streptomycin, 1% nonessential amino acid,
1 mM sodium pyruvate, 1 μg/ml human holo-transferrin, and 1 mM oxaloacetic acid. The
cells were incubated at 37 °C in a humidified atmosphere containing 7.5% CO2 and 92.5%
air. The cells were pretreated with resveratrol (10 μM), sirtinol (10 μM) or 3-
aminobenzidine (3-AB, 1mM) for 2 hrs before treated with cigarette smoke extract (CSE,
0.5% – 5%) for 24 hrs. To avoid induction of autophagy through the serum starvation
pathway, all treatments were done in complete culture medium.
Preparation of cigarette smoke extract
Research grade cigarettes 2R4F were obtained from the Kentucky Tobacco Research and
Development Center at the University of Kentucky (Lexington, KY). These cigarettes
contain 11.7 mg of total particulate matter (TPM), 9.7 mg of tar, and 0.76 mg of nicotine per
cigarette. Cigarette smoke extract (CSE) was prepared by bubbling smoke from one
cigarette into 10 ml serum-free media at a rate of one cigarette/min as described previously
[33–34]. The pH of the CSE was adjusted to 7.4, and was sterile-filtered through a 0.45 μm
filter (25 mm Acrodisc; Pall Corporation, Ann Arbor, MI). CSE preparation was
standardized by measuring the absorbance (OD: 1.00 ± 0.05) at a wavelength of 320 nm.
The pattern of absorbance (spectrogram) observed at 320 nm showed very little variation
between different preparations of CSE. CSE was freshly prepared for each experiment and
diluted with culture media supplemented with 10% FBS immediately before use. Control
medium was prepared by bubbling air through 10 ml serum-free media, adjusting pH to 7.4,
and sterile-filtered as described above.
Transfection
For the autophagy assays, H292 cells were plated on chamber slides and transfected with 1
μg of GFP-LC3 expression construct, a kind gift of Dr. Tamotsu Yoshimori (Osaka
University, Osaka, Japan), using lipofectamineTM 2000 (Invitrogen, CA) according to the
manufacturer’s protocol. Images were captured using a fluorescent microscope (BX51,
Olympus Optical, Tokyo, Japan).
Immunoblotting
Whole cell extracts were separated on a 6.5% to 12% sodium dodecyl sulfate-
polyacrylamide gel by electrophoresis. Separated proteins were transferred onto
nitrocellulose membranes (Amersham, Arlington Heights, IL), and blocked for 1 hr at room
temperature with 5% bovine serum albumin (BSA) (Sigma-Aldrich). The membranes were
then probed with specific primary antibodies of LC3, β-actin (Sigma-Aldrich), SIRT1,
acetylated p53 on lysine 382, GAPDH (Cell Signaling Technology, Beverly, MA) or p53,
poly(ADP-ribose) (Santa Cruz Biotechnology, Santa Cruz, CA) at 4 °C for overnight. After
three washing steps, the levels of protein were detected by probing with secondary anti-
rabbit or anti-mouse antibody linked to horseradish peroxidase for 1 hr, and bound
complexes were detected using the enhanced chemiluminescence method (Perkin Elmer,
Waltham, MA). Equivalent loading of the gel was determined by quantification of protein as
well as by reprobing membranes for β-actin or GAPDH. ImageJ software (Version 1.41,
National Institutes of Health, Bethesda, MD) was used for gel band quantitative
densitometric analysis.
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Animals and cigarette smoke exposure
SIRT1 heterozygous knockout (Sirt1+/−) mice [35] and wild-type mice of genetic
background 129/SvJ were bred and maintained under specific pathogen-free condition in the
vivarium facility of the University of Rochester. These SIRT1 deficient mice and WT
littermates were housed in the vivarium facility of the University of Rochester with a 12 hrs
light/dark cycle (light on at 6:00 am). All animal procedures were approved by the
Committee on Animal Research at the University of Rochester. In brief, mice were exposed
to CS using research grade cigarettes (2R4F, University of Kentucky, Lexington, KY)
according to the Federal Trade Commission protocol (1 puff/min of 2-s duration and 35-ml
volume) with a Baumgartner-Jaeger CSM2072i automatic CS generating machine (CH
Technologies, Westwood, NJ). Mainstream CS was diluted with filtered air and directed into
the exposure chamber. The smoke exposure (TPM in per cubic meter of air) was monitored
in real-time with a MicroDust Pro-aerosol monitor (Casella CEL, Bedford, UK) and verified
daily by gravimetric sampling. The smoke concentration was set at a value of ~300 mg/m3
TPM by adjusting the flow rate of the diluted medical air, and the level of carbon monoxide
in the chamber was 350 ppm [36]. Mice (n=4 per group) received two 1 hr exposures (1 hr
apart) daily for 3 consecutive days and were sacrificed at 24 hrs post-last exposure. Control
mice were exposed to filtered air in an identical chamber according to the same protocol
described for CS exposure. Mice were anesthetized by an intraperitoneal injection of
pentobarbital sodium (100 mg/kg; Abbott Laboratories, Abbott Park, IL) and then sacrificed
by exsanguination 24 hrs after last exposure. The lungs were removed en bloc and frozen for
immunoblot analysis.
Statistical analysis
Data were presented as mean±SEM for three independent repeats of each experiment.
Statistical analysis of significance was calculated using one-way Analysis of Variance
(ANOVA) followed by Tukey’s post-hoc test for multigroup comparisons using StatView
software. P < 0.05 considered as significant whereas P > 0.05 considered as non-significant.
RESULTS
Cigarette smoke extract (CSE) induces autophagy in different lung cell types
We investigated whether CSE could affect the induction of autophagy in different lung cell
types (epithelial cells and fibroblasts), and in macrophages. Treatment of human bronchial
epithelial cells (H292) with CSE caused a dose-and time-dependent increase in the
conversion of LC3-I to LC3-II, a hallmark of autophagic activity (Fig. 1A) [37]. At the
concentration of 1% CSE, approximately 5-fold increase in the amount of LC3-II/LC3-I was
found as compared to controls. CSE (1%) time-dependently increased the LC3-II/LC3-I for
up to 36 hrs following CSE treatment. The formation of GFP-LC3 punctae, a characteristic
during the formation of autophagosomes [37], was also significantly increased in response to
CSE (Fig. 1B), and was correlated with the conversion of LC3-I to LC3-II by immunoblot
analysis. The number of GFP-LC3 dots per cell in CSE-treated H292 cells was also
significantly increased in a dose-dependent manner. Another human bronchial epithelial cell
line Beas-2B also showed the similar results to dose-dependent increase in the conversion of
LC3-I to LC3-II in response to CSE (Fig. 1C). Furthermore, CSE treatment of human fetal
lung fibroblasts (HFL1) and human monocyte-macrophage cell line (MonoMac6) also
caused a dose-dependent increase in the conversion of LC3-I to LC3-II (Fig. 1D). These
data clearly suggest that CSE induces autophagy in different lung cell types.
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SIRT1 activator attenuates CSE-induced autophagy
We recently reported that the levels and activity of SIRT1 are decreased in response to CS
exposure in lungs of smokers and patients with COPD as well as in MonoMac6 and lung
epithelial cells [20,25,30]. Based on this, we hypothesized a decrease in SIRT1 levels/
activity is involved in induction of CS-induced autophagic response. To investigate the role
of SIRT1 in CSE-induced autophagy, H292 cells were pretreated with a non-specific
activator of SIRT1, resveratrol (10 μM) for 2 hrs, followed by treatment with CSE (0.5%
and 1%) for 24 hrs or H2O2 (100 μM) for 1 hr. The levels of SIRT1 were significantly
reduced in response to CSE, whereas resveratrol pretreatment prevented the decrease in
SIRT1 levels in response to CSE (Fig. 2). SIRT1 deacetylase activity was also assessed by
measuring levels of acetylated p53 on lysine 382. CSE significantly increased acetylation of
p53, which was partially attenuated by resveratrol pretreatment. Resveratrol treatment alone
without CSE challenge showed increased levels and activity of SIRT1 but did not affect
induction of autophagy, as assessed by immunoblot analysis of LC3 levels. As shown in Fig.
2, however, pretreatment of H292 cells with resveratrol showed attenuation in levels of
LC3-II/LC3-I in response to CSE and H2O2 as compared to H292 cells that were not
pretreated with resveratrol. These data suggest that resveratrol attenuates CSE-induced
autophagy, implying that decreased levels/activity of SIRT1 under stress condition is
involved in induction of autophagy.
Inhibition of SIRT1 leads to augmentation in CS-induced autophagy
To determine whether the decreased level of SIRT1 was associated with CSE-induced
autophagy, H292 cells were pretreated with pharmacological inhibitor of SIRT1, sirtinol (10
μM). After pretreatment for 2 hrs, cells were treated with CSE (0.5% and 1%) for 24 hrs or
H2O2 (100 μM) for 1 hr and subjected to immunoblot analysis. The levels of SIRT1 were
significantly decreased in response to CSE, which was augmented by pretreatment with
sirtinol (Fig. 3). CSE significantly increased acetylation of p53 on lysine 382 indicating
reduction in SIRT1 activity, which was further enhanced in sirtinol pretreated cells. As
expected, CSE increased induction of autophagy and sirtinol pretreatment further increased
autophagic activity. Interestingly, sirtinol treatment alone without CSE challenge showed
decreased SIRT1 levels and activity but this did not induceLC3-II suggesting that SIRT1
reduction per se is not sufficient to induce autophagy.
To further demonstrate the involvement of SIRT1 in regulation of CS-induced autophagy,
SIRT1 deficient heterozygous (SIRT1+/−) and wild-type (WT) littermate mice were exposed
to CS for 3 days and the levels of autophagy estimated from induction of LC3-II. As shown
in Fig. 4, an increase in conversion of LC3-I to LC3-II was observed in vivo in CS-exposed
SIRT1 deficient and WT mice lung. However, no significant different was seen between air-
exposed SIRT1 deficient and WT mice. These data suggest that SIRT1 has a role in the
induction of autophagy in response to CS but reduction of SIRT1 alone without any stress
was not sufficient to induce autophagy in the lung.
PARP-1 inhibition attenuates CSE-induced autophagy
PARP-1 is a NAD+-dependent nuclear enzyme that generates poly(ADP-ribose) (PAR)
polymer from NAD+. Hence, activation of PARP-1 depletes the nuclear NAD+ pool which
will result in reduction of NAD+-dependent deacetylase SIRT1 activity [30,38,39]. To
determine whether PARP-1 activity contributed to the CSE-induced autophagy via
downregulation of SIRT1 activity, HFL1 fibroblasts were treated with CSE (1%) for 24 hrs
or H2O2 (100 μM) for 1 hr in the presence or absence of PARP-1 inhibitor (3-AB, 1 mM)
for 2 hrs. The formation of PAR polymer was detected by immunoblot assay. As shown in
Fig. 5, PAR polymer formation was induced by CSE treatment accompanied with reduction
in SIRT1 activity. Pretreatment with 3-AB significantly inhibited CSE-induced PAR
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formation and the reduction in SIRT1 activity specifically in HFL1 fibroblasts. Interestingly,
3-AB pretreatment attenuated CSE-induced autophagy, which was similar to the inhibitory
effect of resveratrol on LC3-I to LC3-II conversion. These observations suggest that SIRT1-
PARP-1 axis has a role in induction of autophagy in response to CSE.
DISCUSSION
Recent studies have reported that downregulation of histone deacetylase (HDAC) activity
can induce autophagy. HDAC inhibitors, such as sodium butyrate and suberoylanilide
hydroxamic acid (SAHA) can induce autophagy [40–41]. In addition, Chen et al.
demonstrated that decreased HDAC activity in response to CS triggers autophagy [19].
Despite increasing reports of the association between decreased HDAC activity and
induction of autophagy, little is known about the relationship between decreased SIRT1
deacetylase activity and induction of autophagy especially under oxidative stress conditions.
We tested the hypothesis that SIRT1 plays an important role in regulating CS-mediated
autophagy which is mediated by SIRT1-PARP1 axis in lung cells. We found that reduction
in SIRT1 activity by CS induced autophagy in different lung cell types. SIRT1 activator
resveratrol attenuated CSE-induced autophagy through prevention of SIRT1 reduction,
whereas SIRT1 inhibitor sirtinol enhanced CSE-induced autophagy through SIRT1
reduction.
Recently, Lee et al. demonstrated that SIRT1 upregulates starvation-induced autophagy,
which resulted from deacetylation of the autophagy machinery [32]. SIRT1 is NAD+-
dependent and its activity is regulated by intracellular NAD+ level. Calorie restriction/
starvation increases the NAD+ levels through upregulation of the NAD+ salvage pathway,
thus increasing SIRT1 activity [42]. Unlike calorie restriction, oxidative stress imposed by
CS and H2O2 leads to a decrease in SIRT1 activity possibly via depletion of intracellular
NAD+ pool. Moreover, we and others have shown that SIRT1 activity was decreased in
lungs of smokers and patients with COPD as well as in lung cells exposed to CSE
[20,25,30,43]. Our results are in discordance with the findings of Lee et al for the role of
SIRT1 in upregulating autophagy during starvation stress and suggest that CS or oxidants-
induced autophagy is regulated by another mechanism which is linked with SIRT1.
Huang et al. reported that NAD+-dependent enzyme PARP-1 promotes autophagy under
oxidative stress [44]. Under oxidative stress, PARP-1 is activated and causes rapid depletion
of NAD+, leading to reduction of SIRT1. We found that PARP-1 was activated in response
to CS, as shown by increased formation of PAR polymer, which results in depletion of
NAD+ and subsequent reduction of SIRT1 activity. PARP-1 inhibitor (3-AB) attenuated
CSE-induced autophagy with partial increase in SIRT1 activity specifically in fibroblasts.
These findings suggest that SIRT1-PARP-1 axis is required for regulation of autophagy in
response to CS. Resveratrol is shown to enhance SIRT1-dependent cellular processes,
including life-span extension, cell cycle regulation and apoptosis from yeast to mammals
[45–48]. Hence pharmacological activation of SIRT1 may be beneficial in attenuating
cigarette smoke/oxidants-induced autophagy.
Interestingly, we showed that decrease in SIRT1 activity by pharmacological SIRT1
inhibitor sirtinol could not induce autophagy without stimuli/stresses. This phenomenon was
also confirmed in lung tissues from SIRT1 deficient mice where autophagy was not seen in
lung cells of SIRT1 overexpressing mice or induced by CS in SIRT1 overexpressing mice
(Hwang et al. unpublished data). However, autophagy was induced in lungs of SIRT1
deficient mice when exposed to CS compared to WT mice exposed to CS or SIRT1 deficient
mice alone. We speculated that SIRT1 reduction per se is not sufficient to cause autophagy
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and possibly requires PARP-1 activation and/or other molecules linked with SIRT1 to
trigger autophagy in response to CS.
The mammalian target of rapamycin (mTOR) plays a critical role in maintaining nutrient
and energy status through a pathway that regulates many essential biological processes,
including autophagy. AMP-activated protein kinase (AMPK) is one of the major upstream
regulators of mTOR and its activation stimulates autophagy induction [44,49].
Accumulating evidence suggests the relevance of SIRT1, mTOR and AMPK to a defect in
biological processes, including energy expenditure, muscle loss and senescence [50–52].
Whether AMPK has any role in CS-induced reduction of SIRT1 activity and subsequent
induction of autophagy in lung cells remains to be determined. As AMPK has been well
established as key regulators of autophagy in response to alteration of SIRT1 activity, it is
reasonable to postulate that AMPK may have a direct role in CS-induced reduction of
SIRT1 activity and subsequent induction of autophagy in lung cells.
Intriguingly, SIRT1 and autophagy have been implicated in cellular senescence and aging
[59]. SIRT1 has been shown to regulate aging and longevity in mammals [21], and CS also
induces aging-like alterations in tissue and organ structure [60]. The failure in clearance of
proteins due to decline of autophagy is associated with age-related pathogenesis such as
neurodegenerative disease [61]. CS-induced autophagy is involved in pathogenesis of CS-
mediated lung age-related diseases, such as emphysema and COPD [62]. Emphysema and
COPD are associated with loss of regenerative capacity in lungs and cellular senescence
aggravates adequate cell replacement by autophagy. Based on our data showing CS-
mediated induction of autophagy via SIRT1, it is tempting to speculate that SIRT1 is not
only a key player in regulation of autophagy but also involved in aging and cellular
senescence in smokers.
COPD and lung cancer are CS-associated chronic diseases but a relationship between both
of these conditions with respect to regulation of autophagy is not fully understood [63].
Although we have reported reduction of SIRT1 abundance and activity in lungs of smokers
and patients with COPD [20], it is highly debatable whether SIRT1 functions as tumor
suppressor or tumor promoter [64]. SIRT1 acts as a tumor promoter which deacetylates and
inactivates tumor suppressor genes p53 and p73, leading to down-regulation of p53-and p73-
mediated transcriptional activity [27–28,65]. On the other hand, overexpression of SIRT1
suppressed the age-related transcriptional change and tumor formation [66], which showed
that SIRT1 serves as tumor suppressor. Recent reports showed that resveratrol (an indirect
activator of SIRT1) and its analogs have anti-tumor effects through inhibition of cancer cell
growth and induction of apoptosis in lung cancer cells [67–68]. Although resveratrol showed
promising efficiency as anti-tumor agent, further investigation on the function of SIRT1 in
various lung cancer types and its relevance with COPD is required for the clinical
applications.
In summary, our data show that CS induces autophagy in lung epithelial cells, fibroblasts
and macrophages through the reduction in level and activity of SIRT1. We further showed
that the SIRT1-PARP-1 axis plays a pivotal role in regulation of CS-induced autophagy, as
evidenced by the studies using the pharmacological SIRT1 activator and inhibitor, SIRT1
deficient mice and PARP-1 inhibitor in response to CS. These findings have implications in
understanding the underlying mechanism that CS cause cell death and senescence in chronic
inflammatory lung diseases. Pharmacological activation of SIRT1 may be a novel
therapeutic approach in conditions where oxidative stress plays a critical role in autophagy-
mediated cell death.
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Fig. 1. CSE increases autophagy in different lung cell types
(A) Human bronchial epithelial cells (H292) were treated with indicated concentrations of
CSE for 24 hrs or with 1% CSE for indicated time periods. Cell lysates were subjected to
immunoblot analysis for detection of LC3 levels. GAPDH was used as loading control.
Quantification of results is presented as the amount of LC3-II normalized against LC3-I. (B)
H292 cells were transfected with GFP-LC3 expression plasmid, and treated with CSE (0.5%
and 1%) for 24 hrs. The cells were examined by fluorescent microscopy, and representative
cells were selected and photographed. Autophagic activities were measured by the number
of GFP-LC3 dots per cell at the designed concentration of CSE treatment. (C) Human
bronchial epithelial cell line Beas-2B were treated with indicated concentration of CSE for
24 hrs, and subjected to immunoblot analysis for detection of LC3 levels. (D) Human fetal
lung fibroblasts (HFL1) and human monocyte-macrophage MonoMac6 cells (MM6) were
treated with indicated concentrations of CSE for 24 hrs, and subjected to immunoblot
analysis for detection of LC3 levels. β-actin was used as loading control. The immunoblot
results and microscopic data are representative of three independent repeats of each
experiment. Data are shown as mean ± SEM (n=3). *P < 0.05, **P < 0.01, ***P < 0.001,
significant compared to controls.
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Fig. 2. SIRT1 activation attenuates CSE-induced autophagy
H292 cells were treated with CSE (0.5% and 1%) for 24 hrs or H2O2 (100 μM) alone for 1
hr, pretreatment with or without SIRT1 activator resveratrol (10 μM) for 2 hrs. Whole cell
extracts were used for immunoblot analysis of LC3, SIRT1, acetylated p53 on lysine 382
and p53. β-actin was used as loading control. Quantification of results is presented as the
amount of LC3-II normalized against LC3-I. The immunoblot results are representative of
three independent repeats of each experiment. Data are shown as the mean±SEM (n=3). *P
< 0.05, significant compared to controls; #P < 0.05, ##P < 0.01, significant compared to
absence of resveratrol. ac-p53, acetylated p53 on lysine 382.
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Fig. 3. SIRT1 inhibition enhances CSE-induced autophagy
H292 cells were treated with CSE (0.5% and 1%) for 24 hrs or H2O2 (100 μM) for 1 hr,
pretreatment with or without SIRT1 inhibitor sirtinol (10 μM) for 2 hrs. Whole cell extracts
were used for immunoblot analysis of LC3, SIRT1, acetylated p53 on lysine 382 and p53. β-
actin was used as loading control. Quantification of results is presented as the amount of
LC3-II normalized against LC3-I. The results are representative of three independent repeats
of each experiment. Data are shown as mean±SEM (n=3). ***P < 0.001, significant
compared to controls; #P < 0.05, ##P < 0.01, significant compared to absence of
sirtinol; $$$P < 0.001, significant compared to sirtinol treatment without challenge. ac-p53,
acetylated p53 on lysine 382.
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Fig. 4. SIRT1 deficiency augments CS-induced autophagy in mice lung
Whole lung homogenates from SIRT1 deficient and WT mice exposed to CS for 3 days
were used for immunoblot analysis of LC3 and SIRT1. β-actin was used as loading control.
Quantification of results is presented as the amount of LC3-II normalized against LC3-I.
Data are shown as mean ± SEM (n=4 per group). *P < 0.05 significant compared to air-
exposed WT mice; ##P < 0.01, significant compared to air-exposed SIRT1 deficient mice.
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Fig. 5. PARP-1 inhibition attenuates CSE-induced autophagy
HFL1 cells were treated with CSE (1%) for 24 hrs or H2O2 (100 μM) for 1 hr, pretreatment
with or without PARP-1 inhibitor 3-AB (1 mM) for 2 hrs. Whole cell extracts were used for
immunoblot analysis of LC3, SIRT1, acetylated p53 on lysine 382 and p53. GAPDH was
used as loading control. Quantification of results is presented as the amount of LC3-II
normalized against GAPDH. The immunoblot results are representative of three independent
repeats of each experiment. Data are shown as mean±SEM (n=3). **P < 0.01, ***P < 0.001,
significant compared to controls; ###P < 0.001, significant compared to absence of 3-
AB; $$$P < 0.001, significant compared to 3-AB treatment without challenge. ac-p53,
acetylated p53 on lysine 382.
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